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1  | INTRODUC TION
Experimental and clinical evidence indicates that cardiac contractile 
dysfunction is a complication that significantly enhances the mortality 
of sepsis.1,2 Accumulating evidence demonstrates that cardiomyocyte 
apoptosis associated with mitochondrial damage plays an important 
role in the pathogenesis of sepsis-induced contractile dysfunction.3-6 
Indeed, caspase-3 inhibition has been shown to reduce apoptosis 
and improve cardiac contractile function in an endotoxin-treated rat 
model of sepsis.4 However, the subcellular mechanisms underlying 
mitochondrial damage-induced apoptosis in sepsis are not completely 
understood. Elucidating the mechanisms that mediate apoptosis may 
lead to the development of novel therapeutic targets and strategies 
for the management of sepsis-induced cardiac dysfunction.
Ca2+-calmodulin-dependent protein kinase II (CaMKII) is a 
ubiquitous kinase that is canonically activated by the elevation 
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Abstract
Sepsis is associated with cardiac dysfunction, which is at least in part due to cardio-
myocyte apoptosis. However, the underlying mechanisms are far from being under-
stood. Using the colon ascendens stent peritonitis mouse model of sepsis (CASP), we 
examined the subcellular mechanisms that mediate sepsis-induced apoptosis. Wild-
type (WT) CASP mice hearts showed an increase in apoptosis respect to WT-Sham. 
CASP transgenic mice expressing a CaMKII inhibitory peptide (AC3-I) were protected 
against sepsis-induced apoptosis. Dantrolene, used to reduce ryanodine receptor 
(RyR) diastolic sarcoplasmic reticulum (SR) Ca2+ release, prevented apoptosis in WT-
CASP. To examine whether CaMKII-dependent RyR2 phosphorylation mediates di-
astolic Ca2+ release and apoptosis in sepsis, we evaluated apoptosis in mutant mice 
hearts that have the CaMKII phosphorylation site of RyR2 (Serine 2814) mutated to 
Alanine (S2814A). S2814A CASP mice did not show increased apoptosis. Consistent 
with RyR2 phosphorylation-dependent enhancement in diastolic SR Ca2+ release 
leading to mitochondrial Ca2+ overload, mitochondrial Ca2+ retention capacity was 
reduced in mitochondria isolated from WT-CASP compared to Sham and this reduc-
tion was absent in mitochondria from CASP S2814A or dantrolene-treated mice. We 
conclude that in sepsis, CaMKII-dependent RyR2 phosphorylation results in diastolic 
Ca2+ release from SR which leads to mitochondrial Ca2+ overload and apoptosis.
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of intracellular Ca2+ and more recently, its activity has also been 
shown to be modulated by ROS-dependent oxidation.7,8 CaMKII is 
known to play an important physiological role in the regulation of 
cardiac excitation-contraction coupling.9 However, under patho-
logical conditions CaMKII has been shown be detrimental.10-12 
Indeed, we have recently shown that in sepsis, CaMKII is acti-
vated by oxidation and once active it phosphorylates the cardiac 
ryanodine receptor (RyR2) leading to inappropriate diastolic Ca2+ 
release from the sarcoplasmic reticulum (SR), known as SR Ca2+ 
leak. This SR Ca2+ leak reduces SR Ca2+ content and thus systolic 
Ca2+ release, mediating at least in part the contractile dysfunc-
tion associated with sepsis.13 In addition, CaMKII has been shown 
to be a common intermediate of diverse death stimuli that induce 
apoptosis of cardiac cells.14 Consistent with these results, we have 
previously demonstrated that CaMKII activation is a critical step in 
the signalling cascade that leads to apoptosis in ischaemia/reper-
fusion injury, ouabain toxicity, sustained Angiotensin II stimulation 
and rapid pacing.8,15-17 Moreover, we and others have provided 
evidence demonstrating that CaMKII, through the phosphor-
ylation of the RyR2, enhances SR Ca2+ leak which is then taken 
up by the mitochondria, leading to mitochondrial Ca2+ overload 
which triggers the apoptotic cascade.17-22 The above-mentioned 
events could also hold true for sepsis. Thus, we hypothesized that 
CaMKII-dependent SR-Ca2+ leak mediates apoptosis in sepsis.
The results presented herein, using a colon ascendant stent 
peritonitis (CASP) model of sepsis that closely mimics the clini-
cal course of diffuse peritonitis with early and steadily increas-
ing systemic infection and inflammation,23 enhanced apoptosis 24 
and contractile dysfunction13 provide mechanistic insight on sep-
sis-induced apoptosis. We show that in sepsis, cardiac cell death 
involves CaMKII activation, which through the phosphorylation of 
RyR2 enhances SR-Ca2+ leak leading to mitochondrial Ca2+ over-
load and apoptosis. Importantly, we further show that the RyR2 
plays a critical role in sepsis-induced cell death and that agents 
that reduce RyR2 open probability (RyR2 stabilizers) are effective 
in preventing apoptosis, suggesting a potential therapeutic advan-
tage of these compounds to reduce apoptosis and contractile dys-
function associated with sepsis.
2  | MATERIAL S AND METHODS
All procedures followed during this investigation were approved 
by Animal Welfare Committee of La Plata School of Medicine 
(University of La Plata), following the Guide for the Care and Use 
of Laboratory Animals published by the National Research Council, 
National Academy Press, Washington DC 2010 and/or European 
Union Directive for Animal Experiments 2010/63/EU. Three-month-
old male wild-type (WT) C57BL/6 mice and transgenic (TG) mice with 
cardiomyocyte-delimited transgenic expression of either a CaMKII 
inhibitory peptide (AC3-I) or a scrambled control peptide (AC3-C) 
or mutant mice where the CaMKII-dependent phosphorylation site 
on the RyR2 (site Serine 2814) is mutated to Alanine (S2814A) were 
used. All genetically modified mice were generated on a C57BL/6 
background.
2.1 | Mouse model of sepsis
Colon ascendens stent peritonitis (CASP) surgery was performed 
to induce sepsis as previously described.13 In brief, a small stent 
was inserted into the ascending colon of mice leading to the con-
tinuous leakage of intestinal bacteria into the peritoneal cavity 
resulting in peritonitis and systemic bacteraemia. Sham surgery 
was carried out using the identical surgical procedure, but with-
out stent implantation. For more detail see online Supporting 
Information.
2.2 | Cardiomyocyte isolation
Myocytes were isolated by enzymatic digestion.13 Details are pro-
vided under Supporting Information.
2.3 | Isolation of mouse heart mitochondria
Isolated hearts were washed and homogenized in ice-cold isolation 
solution (IS) consisting of 75 mmol/L sucrose, 225 mmol/L man-
nitol and 0.01 mmol/L EGTA neutralized with Trizma buffer at pH 
7.4. After tissue pieces were settled, the entire supernatant was 
discarded and fresh IS was added and the mixture was transferred 
to a hand homogenizer. Proteinase (0.08 mg, bacterial, type XXIV, 
Sigma,) was added just before starting the homogenization proce-
dure. The homogenate was carefully transferred after each step to 
a polycarbonate centrifuge tube. After 5 minutes of 750 × g of cen-
trifugation to discard unbroken tissue and debris, the supernatant 
was centrifuged at 8000 × g for 10 minutes to sediment the mito-
chondria. The mitochondrial pellet was washed twice with IS and the 
last one with suspension solution (IS without EGTA, SS) at 8000 × g 
for 5 minutes each. The residue was washed and re-suspended in 
SS. The mitochondrial protein concentration was evaluated by the 
Bradford method25 using bovine serum albumin as standard.
2.4 | Apoptosis assessment
Mitochondrial Cytochrome C levels and the ratio between pro- 
and anti-apoptotic proteins Bax and Bcl-2, respectively, were used 
as an index of apoptosis (see online Supporting Information for 
details). Apoptosis was also determined by TUNEL assay (In Situ 
Cell Death Detection Kit, TMR red, Roche, Mannheim, Germany). 
TUNEL-positive cells were imaged under a fluorescence microscope 
(100 × magnification) and counted in 10 random fields from each 
experimental situation. The results were expressed as percentage of 
TUNEL-positive cells related to total number of cells. DAPI (1 µg/mL, 
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4', 6-Diamidino-2-phenylindole dihydrochloride, Sigma, St. Louis, 
MO) was used for nuclear staining.
2.5 | Immunoblotting
Homogenates, cytosolic fractions and SR membranes were pre-
pared from the pulverized ventricular tissue. Proteins were electro-
phoresed and transferred to polyvinylidene fluoride membranes.26 
Blots were probed with antibodies raised against, anti-Bcl2 and anti-
Bax. Immunoreactivity was visualized by a peroxidase-based chemi-
luminescence detection kit (Immobilon Western Millipore) using a 
Chemidoc Imaging System (Bio-Rad, Hercules, CA). Details are pro-
vided in the Supporting Information.
2.6 | Mitochondrial Membrane Potential
Mitochondrial membrane potential changes were evaluated by 
measuring rhodamine-123 (RH-123) fluorescence quenching in 
a buffer containing (in mM): 120 KCl, 20 MOPS, 10 Tris-HCl and 
5 KH2PO4 adjusted to pH = 7.4 containing RH-123 0.1 μmol/L. 
Isolated mitochondria loaded with RH-123 were excited at 503 nm, 
and fluorescence emission was detected at 527 nm.27 During the 
measurements, the reaction medium containing mitochondria 
(0.1 mg/mL) was continuously stirred. Mitochondrial membrane po-
tential (ΔΨm) was calculated following the instructions previously 
detailed using the Nernst-Guggenheim Equation28 According to 
the authors, RH-123 uptake is in proportion to ΔΨm; therefore, the 
rate of fluorescence quenching is a function of ΔΨm, as well as the 
steady-state level of fluorescence decrease.
2.7 | Mitochondrial calcium retention capacity assay
The ability of mitochondria to retain exogenous Ca2+ before the ir-
reversible opening of the mitochondrial permeability transition pore 
(mPTP) occurs was monitored by following the changes in the fluores-
cence of the Ca2+ sensitive indicator, Calcium Green-5N.29 The reac-
tion begins with the addition of successive pulses of 5 µmol/L Ca2+. 
After each addition, the fluorescence in the medium increases until the 
mitochondria start to take up Ca2+ and then it decreases. When mito-
chondria are sufficiently loaded with Ca2+, the opening of the mPTP 
occurs and the release of the mentioned ion in the medium increases 
again the fluorescence.30 For this assay, 0.3 mg/mL of isolated mito-
chondria were suspended in 2 mL buffer containing, 150 mM sucrose, 
50 mM KCl, 2 mM KH2PO4 and 5 mM succinate in 20 mM LTris/HCl, 
(pH 7.4). At the end of the preincubation period (300 s), successive 
pulses of 5 μmol/L Ca2+ were added. Extramitochondrial Ca2+ con-
centration was recorded with 0.5 μM Calcium Green-5N (Invitrogen, 
Carlsbad, CA, USA) with excitation and emission wavelengthsset at 
506 and 532nm, respectively. All experiments were performed at 37°C 
and with continuous stirring.
Calcium retention capacity (CRC) was defined here as the amount 
of Ca2+ required to trigger a massive Ca2+ release by isolated cardiac 
mitochondria.29 CRC is used as an indicator of the resistance of the 
mPTP to opening after matrix Ca2+ accumulation and expressed as 
nmol CaCl2 per mg of mitochondrial proteins.
2.8 | Statistical analysis
The normal distribution of the data was corroborated with the 
Kolmogorov-Smirnov test; unpaired Student's t test, Mann-Whitney 
test and one-way ANOVA were applied accordingly using GraphPad 
Prism 5.0 (GraphPad Software, USA). The data are presented as 
means ± SEM. The level of significance was set at P < .05.
3  | RESULTS
3.1 | Apoptosis is enhanced in a polymicrobial 
model of sepsis
Apoptosis was assessed by four independent methods, in heart ho-
mogenates, cardiomyocytes and cardiac mitochondria isolated from 
colon ascendens stent peritonitis operated mice (CASP) and from 
Sham-operated controls. Heart homogenates, cardiomyocytes and 
cardiac mitochondria were prepared 24 hours after surgery when 
contractile dysfunction is already installed.13 Figure 1 depicts typical 
blots and overall results showing that the ratio between pro-apop-
totic (Bax) and anti-apoptotic (Bcl2) proteins is increased in CASP 
homogenates relative to Sham, indicative of enhanced apoptosis in 
septic hearts. Similarly, mitochondrial cytochrome C content and mi-
tochondrial membrane potential (ΔΨm) were significantly reduced in 
CASP vs Sham hearts showing that mitochondrial pathway-induced 
apoptosis was enhanced in septic hearts. In addition, there was a sig-
nificant increase in TUNEL-positive nuclei in myocytes isolated from 
CASP compared to myocytes isolated from Sham mice.
3.2 | CaMKII mediates apoptosis associated 
with sepsis
We recently reported that CaMKII mediates at least part of the con-
tractile dysfunction associated with sepsis, and several laboratories 
including our own have provided clear evidence that CaMKII is in-
volved in triggering apoptosis in several disease models.15-17,20,31 To 
test whether CaMKII is also involved in sepsis-induced apoptosis, we 
assessed apoptosis in heart homogenates and isolated mitochondria 
from CASP- and Sham-operated transgenic mice, expressing either 
a CaMKII inhibitory peptide, AC3-I, or a scramble non-inhibitory 
peptide, AC3-C. Figure 2 depicts typical blots and overall results of 
apoptotic indexes showing that apoptosis is significantly enhanced 
in hearts of CASP AC3-C mice vs Sham, whereas hearts from AC3-I 
mice are resistant to sepsis-induced apoptosis.
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F I G U R E  1   Polymicrobial model of sepsis is associated with apoptosis. Evaluation of activation of the apoptotic cascade. Representative 
blots and overall results showing that hearts of WT-CASP mice have a significant increase the ratio between Bax and Bcl-2 (Bax/Bcl2) 
relative to Sham controls (n = 4). WT-CASP exhibited a significant decrease in the mitochondrial expression of cytochrome C (CytoC) 
compared to WT-Sham mice (n = 4) (unpaired t test). Myocardial mitochondrial inner membrane potential (ΔΨm) changes were examined 
using rhodamine-123 (RH-123) fluorescence. As shown, ΔΨm measured in isolated mitochondria was significantly lower in WT-CASP 
compared with WT-Sham mice (n = 4) (Mann-Whitney test). The bottom panel shows typical images and overall results of the increase in 
TUNEL-positive cells in myocytes isolated from CASP mice compared to Sham myocytes. Scatter plot shows values from 3-4 independent 
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3.3 | Mechanisms underlying CaMKII-dependent 
apoptosis in sepsi
RyR2 is crucial for physiological myocyte intracellular Ca2+ handling. 
Nevertheless, abnormal Ca2+ handling and Ca2+ leak via the RyR2 have 
recently been shown by us and others to be key determinants of car-
diomyocyte apoptosis under different pathological conditions.20,32,33 
Importantly, we recently showed that, in sepsis, CaMKII-dependent 
RyR2 phosphorylation at site Serine 2814 results in enhanced SR Ca2+ 
leak favouring contractile dysfunction.13 Thus, using transgenic mice 
lacking the RyR2 CaMKII-dependent phosphorylation site, Serine 
2814 (S2814A), we examined the role of this phosphorylation on sep-
sis-induced apoptosis. Figure 3 shows typical blots and overall data 
indicating that, similar to hearts from AC3-I CASP mice, S2814A-CASP 
mice are protected against sepsis-induced apoptosis. In addition, when 
apoptosis was analysed by TUNEL staining, there was no difference 
between myocytes isolated form S2814A Sham and S2814A CASP 
mice. We further tested the involvement of RyR2 in sepsis-induced 
cell death by using dantrolene, a pharmacological compound known 
to reduce RyR2 open probability.34 Figure 4 depicts typical blots and 
average results showing that 7-day treatment of mice with an intra-
peritoneal injection (IP) of the RyR2 stabilizer, dantrolene (20 mg/kg 
body weight), was able to prevent sepsis-induced apoptosis (Details 
are provided in the Supporting Information). Taken together, these re-
sults suggest that CaMKII-dependent RyR2 phosphorylation, possibly 
through the enhancement of SR Ca2+ leak, is functionally involved in 
F I G U R E  2   CaMKII mediates sepsis-induced cardiac apoptosis. Representative immunoblots and overall results from heart homogenates 
and isolated mitochondria from CASP- and Sham-operated transgenic mice expressing a CaMKII inhibitory peptide (AC3I) or mice expressing 
the scrambled control peptide (AC3C). CASP-AC3C mice show a significant increase in Bax/Bcl2, a significant decrease in mitochondrial 
cytochrome C expression (unpaired t test) and a significant decrease in ∆ψm compared to Sham AC3C (n = 4) (Mann-Whitney test). AC3I-
CASP mice did not show altered apoptotic indexes compared to mice to AC3I-Sham mice (n = 4) indicating that CaMKII inhibition protects 
hearts from sepsis-induced-apoptosis. Data are expressed as means ± SEM * P < .05 vs Sham
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sepsis-induced cell death. Enhanced Ca2+ leak from the SR has been 
shown to promote mitochondrial Ca2+ overload, resulting in the open-
ing of the mitochondrial permeability transition pore (mPTP) and ac-
tivation of the apoptotic cascade.17,20,35 To assess whether this is the 
mechanism underlying sepsis-induced cell death, we measured the 
Ca2+ retaining capacity (CRC) of mitochondria isolated from Sham and 
CASP wild-type mice. For this purpose, we performed experiments 
using Calcium Green-5N to measure extramitochondrial Ca2+ lev-
els (Figure 5). In these experiments, 5 µmol/L Ca2+ addition to mito-
chondria isolated from wild-type Sham-operated mice resulted in a 
rapid increase in Calcium Green fluorescence followed by a decline 
in the fluorescence intensity of the sensor. This slower decrease of 
fluorescence after Ca2+ addition is consistent with mitochondrial 
Ca2+ uptake.36 After sequential administration of 5 µmol/L pulses of 
F I G U R E  3   Preventing RyR2 phosphorylation protects against apoptosis induced by sepsis in mice. Typical Western blots, images 
and overall results showing that CASP-operated S2814A mice do not show significant alterations in the apoptotic indexes Bax/Bcl2, 
mitochondrial cytochrome C expression, ∆ψm or TUNEL staining (n = 4 per group) compared to Sham-operated S2814A mice. All data are 
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Ca2+, mitochondrial CRC is exceeded and stored mitochondrial Ca2+ 
is released into the extramitochondrial space through the opening of 
the mPTP. As observed in the typical traces shown in Figure 5A, mi-
tochondria isolated from CASP-operated C57 mice resisted the addi-
tion of significantly fewer 5 µmol/L pulses of Ca2+ before the opening 
of the mPTP, suggesting that these mitochondria have higher resting 
intramitochondrial Ca2+ than Sham. In addition, Figure 5B depicts typi-
cal tracings and overall results of mitochondrial CRC showing that mi-
tochondria isolated from S2814A mutant CASP mice have preserved 
CRC compared to Sham. Similar results were obtained in dantrolene-
pretreated CASP and Sham mice (Figure S1), confirming that mitochon-
dria isolated from CASP mice are overloaded with Ca2+ resulting from 
CaMKII-dependent RyR2 Ca2+ leak.
4  | DISCUSSION
Our previous study demonstrates that CaMKII-dependent SR-Ca2+ 
leak reduces the cytosolic Ca2+ transient amplitude, contributing to 
the reduced contractility associated with sepsis.13 In addition, sev-
eral reports have proposed myocyte cell death by apoptosis as a crit-
ical process that contributes to contractile dysfunction of the septic 
heart.37-39 Interestingly, sustained activation of CaMKII has been 
shown to be pro-apoptotic.10 Indeed, experimental evidence from 
our laboratory demonstrates that CaMKII activation is a primary 
event in the signalling cascade that leads to apoptosis in ischaemia/
reperfusion injury, ouabain toxicity, rapid pacing and under sustained 
Angiotensin II stimulation.8,15-17 These results suggest that CaMKII, 
in addition to mediating a reduction in myocyte Ca2+ transient am-
plitude in sepsis, could favour the apoptotic process. However, the 
subcellular mechanisms underlying CaMKII-dependent apoptosis in 
sepsis have yet to be determined. Thus, in the present study, using a 
colon ascendens stent peritonitis (CASP) mouse model that closely 
mimics the clinical situation of abdominal sepsis, we investigated the 
mechanisms involved in CaMKII-dependent apoptosis.
Consistent with previous reports, we confirmed that the CASP 
model of sepsis promotes cardiac apoptosis, as evidenced by an en-
hanced ratio between pro- and anti-apoptotic proteins, Bax and Bcl2, 
respectively (Bax/Bcl2), a decrease in mitochondrial cytochrome C 
levels, a significant decrease in mitochondrial membrane potential 
and by an increase in TUNEL staining. These results showing altered 
mitochondrial homeostasis further suggest that cardiac myocyte cell 
death, in sepsis, is mediated at least in part, by the mitochondrial 
pathway of apoptosis.
4.1 | CaMKII mediates sepsis-induced cell death
Oxidative stress has been shown to be enhanced in sepsis, and ex-
perimental evidence demonstrates that antioxidants can prevent 
F I G U R E  4   Reducing RyR2 open 
probability prevents sepsis-induced-
apoptosis. Typical blots and overall 
results of the effect of dantrolene 
pretreatment on sepsis-induced apoptosis. 
WT-CASP + dantrolene mice hearts 
showed non-significant (NS) changes in 
Bax/Bcl2, mitochondrial cytochrome 
C expression and ∆ψm compared to 
Sham + dantrolene-operated WT mice 
(n = 4 per group). All data are expressed 
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cardiac dysfunction associated with sepsis.40,41 Interestingly, we re-
cently showed that oxidative activation of CaMKII leads to the phos-
phorylation of RyR2 site Serine 2814, promoting SR Ca2+ leak which 
in turn reduces SR Ca2+ content and contractility in the CASP model 
of sepsis.13 In addition, activation of CaMKII has been shown to be a 
common intermediate of diverse death stimuli that induce apoptosis 
in cardiac cells.14 Taken together, these results suggest that oxidative 
activation of CaMKII could underlie sepsis-induced apoptosis. The 
results presented herein using a transgenic mouse model express-
ing a CaMKII inhibitory peptide (AC3-I) show that CaMKII mediates 
sepsis-induced cardiomyocyte apoptosis. Interestingly and consist-
ent with our previously published results,13 CASP-operated AC3-I 
mice had a higher survival rate than CASP-AC3-C mice (see results 
in Supporting Information). To our knowledge, these are the first 
results showing that CaMKII inhibition can prevent sepsis-induced 
apoptosis.
4.2 | Mechanism underlying CaMKII-dependent 
apoptosis in sepsis
Recent experimental evidence from our laboratory, in the set-
ting of ischaemia and reperfusion injury, suggests that CaMKII 
may promote apoptosis by altering the coupling between SR Ca2+ 
release and mitochondrial Ca2+ uptake, resulting in mitochondrial 
Ca2+ overload and opening of the mPTP.20 Indeed, the interplay be-
tween SR and mitochondria under different stimuli has been known 
for many years to be pivotal in triggering apoptotic signals.18,19 
Supporting the critical role played by the SR/mitochondrial in-
teraction in CaMKII-dependent apoptosis, Zhang et al concluded 
that enhanced activity of CaMKII results in RyR2 phosphorylation 
leading to enhanced SR Ca2+ leak and mitochondrial Ca2+ eleva-
tion, associated with exacerbated cell death in transgenic mice 
lacking phospholamban and overexpressing CaMKIIαδc.33 Thus, 
we hypothesized that sepsis-induced cell death could be, at least 
in part, due to CaMKII-dependent post-translational modification 
of the RyR2 resulting in SR Ca2+ leak which would be taken up 
by the mitochondria provoking mitochondrial Ca2+ overload. To 
test this hypothesis, we used myocytes isolated from transgenic 
mice with RyR2 site Serine 2814 mutated to Alanine (S2814A) 
and therefore not phosphorylatable by CaMKII. We observed 
that S2814A CASP mice were protected from sepsis-induced ap-
optosis (Figure 3). Moreover, CASP-operated S2814A mice had a 
higher survival rate than CASP-operated WT mice (see results in 
Supporting Information). We have previously shown that CASP 
S2814A mice have a similar degree of CaMKII activation than CASP 
wild-type mice. Moreover, site Thr17 of phospholamban, a spe-
cific target of CaMKII, also has a similar level of phosphorylation 
F I G U R E  5   Role of mitochondrial Ca2+ in sepsis. A, Typical tracings of changes in the fluorescence of Ca2+ indicator Calcium Green-
5N. Arrows indicate Ca2+ addition to the mitochondrial suspension. Increasing extramitochondrial Ca2+ results in a rapid increase in the 
fluorescent signal followed by a decline in the fluorescence intensity of the sensor resulting from mitochondrial Ca2+ uptake. WT-Sham 
mitochondria showed enhanced tolerance to extramitochondrial Ca2+ addition compared to WT-CASP mitochondria. The measurement 
of extramitochondrial Ca2+ shows that WT-Sham cardiac mitochondria are able to accumulate significantly more Ca2+ than WT-CASP 
mitochondria (CRC) (n = 4). Mann-Whitney test results are expressed as mean ± SEM. B: Typical traces and overall results of changes of 
Calcium Green fluorescence after Ca2+ addition in samples of mitochondria from S2814A mutant CASP mice CASP mice compared to Sham. 
Mitochondria from CASP mice showed preserved CRC compared to Sham (n = 4). Unpaired t test, results are expressed as mean ± SEM
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in CASP wild-type mice and in CASP Ser2814A mice, confirming 
that CASP wild-type and CASP Ser2814A mice have a similar level 
of CaMKII activation.13 Thus, Ser2814A mice are protected from 
apoptosis due to the absence of CaMKII-dependent RyR2 phos-
phorylation in spite of CaMKII being able to phosphorylate other 
targets. These results suggest that in sepsis, CaMKII-dependent 
RyR2 phosphorylation is critical for triggering apoptosis. Recent 
evidence suggests that CaMKII can also directly regulate mito-
chondrial Ca2+ uptake by the uniporter, leading to mitochondrial 
Ca2+ overload and mPTP opening.21 Although we cannot exclude 
the mitochondrial uniporter as an additional target for CaMKII 
contributing to enhanced apoptosis in sepsis, our results showing 
that hearts from S2814A CASP mice are protected from apoptosis 
suggest that CaMKII-dependent uniporter phosphorylation is not 
a prerequisite for sepsis-induced apoptosis.
High-resolution Cryo-EM studies have allowed the building of an 
atomic level model of the RyR channel core and cytoplasmic shell, 
permitting a better understanding of channel structure and func-
tion.42 The emerging model is that the RyR is a large complex of 
interconnecting helices which enable allosteric coupling and confor-
mational changes between the shell and the pore of the channel that 
facilitate a range of stimuli to exert control over channel function.43 
Dantrolene is a therapeutic agent used to treat malignant hyper-
thermia, and experimental studies have shown that it also protects 
against heart failure and arrhythmias by inhibiting Ca2+ release from 
the SR. Although the mechanism of action of dantrolene is not com-
pletely understood, Ye Win Oo et al showed that dantrolene inhibits 
RyRs by destabilizing their open state and stabilizing their closed 
state. Several studies provide evidence that dantrolene modulates 
interdomain interactions and that calmodulin binding to the RyR 
is required to produce dantrolene-induced channel inhibition.44-46 
Interestingly, a recent report has shown that dantrolene preserves 
cardiac mitochondria and prevents contractile dysfunction associ-
ated with sepsis.34 However, if this compound can also prevent sep-
sis-induced apoptosis has not been evaluated. Consistent with this 
possibility, we recently reported that rapid pacing-induced apopto-
sis, which is also CaMKII dependent, can be prevented by reducing 
RyR2 open probability with the carvedilol-non-β-blocking analog, 
VK-II-86.20 Thus, we hypothesized that reducing RyR2 open proba-
bility with dantrolene could be effective preventing sepsis-induced 
cell death. We show herein that dantrolene treatment is able to pre-
vent sepsis-induced cell death (Figure 4) and that this treatment also 
enhances survival rate of CASP-operated WT mice (see results in 
online Supporting Information). These results highlight the possibil-
ity of using RyR2 stabilizers as a therapeutic strategy to reduce the 
adverse remodelling associated sepsis.
To assess whether CaMKII-dependent increase is SR Ca2+ leak 
results in mitochondrial Ca2+ overload, we measured mitochon-
drial CRC in mitochondria isolated from Sham and CASP mice. As 
observed in Figure 5A, CRC was significantly reduced in wild-type 
CASP mitochondria, suggesting that these mitochondria were Ca2+ 
overloaded and therefore tolerated less Ca2+ loading until mPTP 
opening compared to Sham. Consistent with mitochondrial Ca2+ 
overload resulting from CaMKII-dependent RyR2 phosphorylation 
and enhanced Ca2+ leak from the SR, the decrease in CRC observed 
in CASP mitochondria was absent in CASP mitochondria isolated 
from S2814A mice (Figure 5B) and from mice treated with dantro-
lene (Figure S1). Taken together, and similar to the conclusion of 
Zhang et al33 our results suggest that sepsis-induced CaMKII acti-
vation leads, at least in part, to an increase in RyR2 open probability 
and Ca2+ leak from the SR, which would result in mitochondrial Ca2+ 
overload, mPTP opening and cytochrome C release which would 
trigger the apoptotic cascade.
Limitations: Our results using dantrolene suggest that reducing 
RyR2 open probability can protect the heart from sepsis-induced 
apoptosis and improve survival. However, dantrolene also targets 
RyR1 which has been shown to be localized in mitochondria.47,48 
Thus, the protective effect of dantrolene could, at least in part, be 
due to its impact on RyR1. Our results using transgenic mice which 
have a specific point mutation of RyR2 site Serine 2814 mutated to 
Alanine show that these mice are protected from sepsis-induced 
apoptosis providing solid evidence that RyR2 is the RyR isoform in-
volved in sepsis-induced apoptosis. Supporting this contention, we 
did not observe significant differences in mitochondrial Ca2+ uptake 
between Sham and Sham dantrolene-treated WT mice suggesting 
that mitochondrial RyR1 inhibition is not involved in the anti-apop-
totic effects of dantrolene (Figure S2). Based on these observations, 
it is likely that the protective effect of dantrolene is mainly due to its 
effect on RyR2. Another potential limitation of our study is that we 
did not examine the mechanism underlying the enhanced survival of 
dantrolene-treated mice. However, considering our previous results 
showing that CASP S2814A mice have preserved ejection fraction, 
SR Ca2+ content, Ca2+ transient amplitude and enhanced survival13 
and those of a recent report demonstrating that dantrolene im-
proves mitochondrial and contractile function in a model of sepsis 
induced by LPS administration,34 it is likely that the improvement 
in survival of dantrolene-treated CASP mice is due to its ability to 
reduce SR diastolic Ca2+ release and ameliorate Ca2+ handling and 
mitochondrial function in CASP mice. Future experiments designed 
to assess Ca2+ handling in dantrolene-treated CASP and Sham mice 
would be important to directly answer these limitations.
In summary, our results show for the first time that CaMKII plays 
a pivotal role in sepsis-induced apoptosis. In addition, our results 
shed mechanistic insight indicating that CaMKII-dependent RyR2 
phosphorylation promotes SR Ca2+ leak that results in mitochondrial 
Ca2+ overload which triggers apoptosis. More importantly, our re-
sults showing that stabilizing the RyR2 with dantrolene can prevent 
sepsis-induced cell death suggests the potential use of this agent 
for the treatment of the adverse remodelling associated with sepsis. 
Taken together, these findings propose CaMKII and RyR2 as new 
therapeutic targets whose inhibition or stabilization, respectively, 
could serve to ameliorate the cardiac symptoms of sepsis.
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